CAS 1182-87-2: Peruvoside
Formula:C30H44O9
InChI:InChI=1S/C30H44O9/c1-16-24(33)26(36-3)25(34)27(38-16)39-19-6-10-29(15-31)18(13-19)4-5-22-21(29)7-9-28(2)20(8-11-30(22,28)35)17-12-23(32)37-14-17/h12,15-16,18-22,24-27,33-35H,4-11,13-14H2,1-3H3/t16-,18+,19-,20+,21-,22+,24-,25-,26+,27-,28+,29+,30-/m0/s1
InChI key:InChIKey=PMTSPAGBAFCORP-HBUONDEYSA-N
SMILES:C(=O)[C@@]12[C@@]3([C@]([C@]4(O)[C@](C)(CC3)[C@H](CC4)C=5COC(=O)C5)(CC[C@@]1(C[C@@H](O[C@H]6[C@@H](O)[C@H](OC)[C@@H](O)[C@H](C)O6)CC2)[H])[H])[H]
Synonyms:- (3beta,5beta)-3-((6-Deoxy-3-O-methyl-alpha-L -glucopyranosyl)oxy)-14-hydroxy-19-oxocard-20(22)-enolide
- (3beta,5beta,8xi,9xi)-3-[(6-deoxy-3-O-methyl-alpha-D-glycero-hexopyranosyl)oxy]-14-hydroxy-19-oxocard-20(22)-enolide
- (3β,5β)-3-[(6-Deoxy-3-O-methyl-α-<span class="text-smallcaps">L</span>-glucopyranosyl)oxy]-14-hydroxy-19-oxocard-20(22)-enolide
- 3-((6-Deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy)-14-hydroxy-19-oxo-card-20(22)-enolide
- 3-[(6-deoxy-3-O-methylhexopyranosyl)oxy]-14-hydroxy-19-oxocard-20(22)-enolide
- Cannogenin alpha-L-thevetoside
- Cannogenin thevetoside
- Cannogenin α-<span class="text-smallcaps">L</span>-thevetoside
- Card-20(22)-enolide, 3-((6-deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy)-14-hydroxy-19-oxo-, (3-beta,5-beta)-
- Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-α-<span class="text-smallcaps">L</span>-glucopyranosyl)oxy]-14-hydroxy-19-oxo-, (3β,5β)-
- Encordin
- See more synonyms
Sort by
Found 6 products.
Peruvoside
CAS:Peruvoside is a natural cardiac glycoside that inhibits Na+/K+-ATPas; cleukemia G₂/M phase; NSCLC Src inhibitor; MAPK Wnt / β-catenin and PI3K / AKT / mTOR.Formula:C30H44O9Color and Shape:SolidMolecular weight:548.67Peruvoside
CAS:Controlled ProductApplications Peruvoside is a cardiac glycoside with the same inotropic and chronotropic effects on heart function as Ouabain (O714500). References Ballica, R., et al.: Biotech. Bioeng., 41, 1075 (1993), Chattopadhyay, S., et al.: J. Biosci. Bioeng., 93, 215 (2002), Dong, H., et al.: Enzyme Microb. Technol., 31, 116 (2002),Formula:C30H44O9Purity:90%Color and Shape:NeatMolecular weight:548.66Peruvoside
CAS:Peruvoside is a cardiac glycoside, which is a bioactive compound derived from the plant source Nerium oleander. This compound functions by specifically inhibiting the Na+/K+-ATPase pump, a critical membrane-bound enzyme responsible for maintaining the electrochemical gradient across the cell membrane. By disrupting the function of this pump, peruvoside leads to an increase in intracellular sodium concentration, which indirectly affects calcium ions via the sodium-calcium exchanger mechanism. This results in enhanced cardiac contractility, making peruvoside useful for certain therapeutic applications. In scientific research, peruvoside is explored primarily for its potential in treating heart conditions by improving cardiac output in patients with heart failure. Additionally, its unique mechanism of action renders it a compound of interest in oncology research, where its influence on cellular ion homeostasis may contribute to anti-tumor activities in specific cancer cells. Given its potent bioactivity, the compound also serves as a focus in studies investigating the underlying pathways of cardiac glycosides and their broader physiological impacts.Formula:C30H44O9Purity:Min. 95%Color and Shape:PowderMolecular weight:548.66 g/mol
